Blog
Featured post
Truveta Data now includes more than 120 million de-identified patients
Truveta has also partnered with more than 100 organizations across life sciences, healthcare, public health, academic research organizations, and others to use regulatory-grade EHR data enabling scientifically rigorous research.
Trends in testing and diagnosis of peripheral vascular disease in the US
The analysis was based on a sample of 17,501,982 patients from January 2018 to May 2024. During the study period, 9,271 patients were tested (using CPT code 93922) for the first...
GLP-1 RA prescription trends: January 2018 – June 2024
Overall prescribing rates (GLP-1 RA prescriptions per total prescriptions) in June 2024 increased slightly relative to March 2024 (+8.43%). Month-over-month anti-diabetic...
Truveta Symposium brings together healthcare, public health, and life science organizations with a shared mission of Saving Lives with Data
Today, Truveta kicks off Truveta Symposium, a unique event bringing together leaders from health systems, life sciences, and the government to collaborate on health research with...
Real-world data study comparing Mounjaro and Ozempic for weight loss published in JAMA Internal Medicine
Truveta Research's comparative effectiveness study exploring weight loss among patients taking semaglutide (Ozempic) and tirzepatide (Mounjaro) has been published in JAMA...
Truveta Data used in new study finds increased use of CGM in patients with type 2 diabetes initiating GLP-1 medications
Citation Wang X, Xu Y, Norman G, et al. CGM Use in People with Type 2 Diabetes Initiating GLP-1 or GIP/GLP-1RA Therapy—Real-World Data. Diabetes. June 14, 2024....
Delivering accuracy and explainability for AI
In this post, I would like to discuss the way we addressed the following challenge: How to ensure that the AI technologies used in our platform have requisite accuracy and...
Truveta supports regulatory submissions to the FDA and global regulatory authorities
Truveta now offers regulatory and audit capabilities to support our customers for real-world evidence (RWE) submissions to the Food and Drug Administration (FDA) and other global...
Migraine research unveiled: Insights from real-world EHR data and notes
One in every four US households has someone living with migraine. More than a severe headache, migraine is a complex neurological disorder impacting 39 million Americans with...
Trends in PSA testing to screen for prostate-related conditions, including cancer
There are mixed prostate-specific antigen (PSA) screening recommendations for men of varying ages. The objective of this study was to describe variation in first-time PSA values...